Efficacy Of Macmiror® In The Therapy Of Giardiasis Invasion In Children With Chronic Hapatitis B

  • Nurmatova Nargiza Fatkhullayevna, Inoyatova Flora Ilyasovna, Asilbekova Malokhat Azadovna, Mirsalikhova Nargis Khayrullayevna

Abstract

Application of three-stage therapy of giardiasis in 250 children with CHB, using MACMIROR®,
Albendazole, and Metronidazole at the second stage of effecting the parasite and its elimination from
the organism, provided achievement of clinical-biochemical remission in 91.1%, 72.5% and 52,5%
cases, and parasite elimination in 93.3%, 32.5% and 60.0% cases, respectively. It should be noted, that
in the conditions of administration of Trichopolum, in spite of the high rate of G.Lamblia elimination,
the therapy was associated with the expressed hepatic toxicity, making recommendation of it for that
category of children impossible. Thus, the first line agent for a specific therapy of giardiasis in children
with CHB is MACMIROR®, due to its efficacy and safety.

Published
2020-06-01
How to Cite
Nurmatova Nargiza Fatkhullayevna, Inoyatova Flora Ilyasovna, Asilbekova Malokhat Azadovna, Mirsalikhova Nargis Khayrullayevna. (2020). Efficacy Of Macmiror® In The Therapy Of Giardiasis Invasion In Children With Chronic Hapatitis B. International Journal of Advanced Science and Technology, 29(7), 9619-9623. Retrieved from http://sersc.org/journals/index.php/IJAST/article/view/26470
Section
Articles